Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Prelude Therapeutics Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 61 | 75 | +14 |
| Shares | 36.0M | 35.2M | −815.4K (−2.3%) |
| Value | $1.12B | $437.6M | −$686.3M (−61.1%) |
New holders (26)
Institutions that held Prelude Therapeutics Inc at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (12)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Federated Hermes, Inc. | 408,100 | $12.8M |
| Logos Global Management LP | 400,000 | $12.5M |
| Rafferty Asset Management, LLC | 36,936 | $1.15M |
| Parametric Portfolio Associates LLC | 10,130 | $317.0K |
| Rhumbline Advisers | 9,275 | $290.0K |
| SG Americas Securities, LLC | 8,691 | $272.0K |
| Virtu Financial LLC | 7,940 | $248.0K |
| Credit Suisse AG | 6,950 | $216.0K |
| MetLife Investment Management | 4,148 | $129.6K |
| Metropolitan Life Insurance Co | 3,194 | $99.8K |
| Jacobi Capital Management LLC | 250 | $8.00K |
| Parallel Advisors, LLC | 38 | $1.00K |